These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 21200023)

  • 61. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
    Kopkova A; Sana J; Fadrus P; Slaby O
    Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High Level of IL-10 in Cerebrospinal Fluid is Specific for Diagnosis of Primary Central Nervous System Lymphoma.
    Shao J; Chen K; Li Q; Ma J; Ma Y; Lin Z; Kang H; Chen B
    Cancer Manag Res; 2020; 12():6261-6268. PubMed ID: 32801871
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A rapid genotyping panel for detection of primary central nervous system lymphoma.
    Gupta M; Burns EJ; Georgantas NZ; Thierauf J; Nayyar N; Gordon A; Jones SS; Pisapia M; Sun Y; Burns RP; Velarde J; Jordan JT; Frigault MJ; Nahed BV; Jones PS; Barker FG; Curry WT; Gupta R; Batchelor TT; Romero JM; Brastianos PK; Marble HD; Martinez-Lage M; Tateishi K; Lennerz JK; Dietrich J; Cahill DP; Carter BS; Shankar GM
    Blood; 2021 Aug; 138(5):382-386. PubMed ID: 33735913
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma.
    Zhang Y; Zou D; Yin J; Zhang L; Zhang X; Wang W; Zhang M; Zhou D; Zhang W
    BMC Cancer; 2021 Feb; 21(1):183. PubMed ID: 33618687
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Plasma miR-92a-2 as a biomarker for small cell lung cancer.
    Yu Y; Zuo J; Tan Q; Zar Thin K; Li P; Zhu M; Yu M; Fu Z; Liang C; Tu J
    Cancer Biomark; 2017; 18(3):319-327. PubMed ID: 28106539
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
    Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
    Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.
    Tang JF; Yu ZH; Liu T; Lin ZY; Wang YH; Yang LW; He HJ; Cao J; Huang HL; Liu G
    Asian Pac J Cancer Prev; 2014; 15(18):7575-81. PubMed ID: 25292031
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
    Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS
    Oncology; 2019; 97(3):173-179. PubMed ID: 31216561
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
    J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma.
    Si PP; Zhou XH; Qu ZZ
    J Immunol Res; 2022; 2022():5052609. PubMed ID: 35497882
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
    Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
    Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.
    Kimura A; Takemura M; Serrero G; Yoshikura N; Hayashi Y; Saito K; Inuzuka T
    J Neurooncol; 2018 May; 137(3):455-462. PubMed ID: 29340960
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Circulating microRNAs as biomarkers of adult Crohn's disease.
    Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
    Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
    Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.
    Rimelen V; Ahle G; Pencreach E; Zinniger N; Debliquis A; Zalmaï L; Harzallah I; Hurstel R; Alamome I; Lamy F; Voirin J; Drénou B
    Acta Neuropathol Commun; 2019 Mar; 7(1):43. PubMed ID: 30885253
    [No Abstract]   [Full Text] [Related]  

  • 78. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
    Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNAs as Diagnostic Biomarkers in Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis.
    Zheng X; Li P; Dong Q; Duan Y; Yang S; Cai Z; Chen F; Li W
    Front Oncol; 2021; 11():743542. PubMed ID: 34604087
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.
    Bruno A; Labreche K; Daniau M; Boisselier B; Gauchotte G; Royer-Perron L; Rahimian A; Lemoine F; de la Grange P; Guégan J; Bielle F; Polivka M; Adam C; Meyronet D; Figarella-Branger D; Villa C; Chrétien F; Eimer S; Davi F; Rousseau A; Houillier C; Soussain C; Mokhtari K; Hoang-Xuan K; Alentorn A
    Neuro Oncol; 2018 Jul; 20(8):1092-1100. PubMed ID: 29432597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.